Analysts Set Teleflex Incorporated (NYSE:TFX) Price Target at $252.50

Teleflex Incorporated (NYSE:TFX) has earned an average recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $252.50.

A number of research firms have weighed in on TFX. Truist Financial reduced their target price on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Royal Bank of Canada reduced their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Finally, Mizuho lowered their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st.

Institutional Trading of Teleflex

Institutional investors and hedge funds have recently modified their holdings of the business. JPMorgan Chase & Co. lifted its holdings in shares of Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock valued at $38,374,000 after purchasing an additional 19,466 shares in the last quarter. Principal Financial Group Inc. raised its position in Teleflex by 2.7% in the 3rd quarter. Principal Financial Group Inc. now owns 80,409 shares of the medical technology company’s stock worth $19,887,000 after buying an additional 2,086 shares during the last quarter. American Trust bought a new position in Teleflex during the 3rd quarter valued at about $212,000. Franklin Resources Inc. boosted its holdings in shares of Teleflex by 64.3% during the 3rd quarter. Franklin Resources Inc. now owns 9,683 shares of the medical technology company’s stock valued at $2,298,000 after acquiring an additional 3,790 shares during the last quarter. Finally, Tidal Investments LLC grew its stake in shares of Teleflex by 29.7% in the third quarter. Tidal Investments LLC now owns 8,014 shares of the medical technology company’s stock worth $1,982,000 after acquiring an additional 1,837 shares during the period. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

Shares of TFX stock opened at $177.98 on Wednesday. The company has a market capitalization of $8.27 billion, a P/E ratio of 35.38, a PEG ratio of 1.84 and a beta of 1.16. Teleflex has a fifty-two week low of $171.69 and a fifty-two week high of $256.85. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock has a 50 day moving average price of $194.29 and a two-hundred day moving average price of $217.89.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. The business had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company’s revenue was up 2.4% on a year-over-year basis. During the same quarter last year, the firm earned $3.64 EPS. Analysts expect that Teleflex will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Friday, November 15th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.76%. The ex-dividend date of this dividend was Friday, November 15th. Teleflex’s dividend payout ratio (DPR) is currently 27.04%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.